Brief: Foghorn Therapeutics Inc. - Cash, Cash Equivalents And Marketable Securities Of $424.7 Million, As Of March 31, 2022, Provides Significant Cash Runway
09/05/2022 12:31
May 9 (Reuters) - Foghorn Therapeutics Inc. FHTX.O :
* FOGHORN THERAPEUTICS INC. - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES OF $424.7 MILLION, AS OF MARCH 31, 2022,
PROVIDES SIGNIFICANT CASH RUNWAY
Source text for Eikon: ID:nGNX1fcx3j
Further company coverage: FHTX.O
((Reuters.Briefs@thomsonreuters.com;))